Future-Proofing Biopharma Procurement Amid Growing External Complexity

Building Resilient Supplier Relationships, Leveraging AI-Driven Efficiency & Maximizing Value Through More Strategic Procurement

R&D procurement has never carried more weight. Outsourcing now accounts for roughly a quarter of pharma R&D costs, and supplier consolidation is shrinking your options. Tariffs and the BIOSECURE Act are redrawing global supply chains, and your team is expected to deliver more with the same headcount.

The 11th R&D Procurement & Sourcing in Pharma Summit returns to Boston as the only event built exclusively for biopharma R&D procurement. It unites clinical, preclinical and strategic sourcing leaders from pharma and biotech in one focused, single-track room. The summit is pharma- and biotech-led, never vendor-led, with real case studies, candid peer discussion and interactive sessions where you build, not just listen.

New for 2027, the AI Real-World Implementation Day moves AI from pilot to practice. Benchmark your AI maturity against peers, see live deployments and build your own agentic workflow before you leave.

The summit arrives less than three months after the first BIOSECURE list of biotechnology companies of concern is due. That makes it your moment to stress-test your supply base and sharpen your category strategy. You’ll return with a completed vendor scorecard, practical strategies for tariffs and scarce capacity, and a network of peers facing the same challenges you do.

Download the Agenda

Enjoyed connecting with procurement peers and gaining insight into how different organizations are embedding AI into both day-to-day operations and broader strategic initiatives. The discussions were highly engaging and thought-provoking, and the energy and enthusiasm throughout the event made it a particularly valuable experience.

Director, Sourcing & Procurement, Biote

The networking opportunities and chance to exchange ideas with fellow procurement professionals were among the most valuable aspects of the event. I particularly appreciated the strong focus on real-world Pharma and Biotech experiences, with discussions centred on practical R&D procurement challenges, strategies, and solutions.

Senior Director, Global R&D Procurement, Chiesi Farmaceutici

The topics were highly relevant to the current challenges and opportunities facing Clinical R&D sourcing. The diversity of speakers, representing both large and emerging organizations, brought a broad range of perspectives that helped foster greater alignment across the industry. Hearing how different companies are approaching similar issues made the discussions especially insightful and practical.

Associate Director - Global Sourcing and Procurement, Research & Development Services, BioMarin Pharmaceutical

All the key decision makers and contacts we were looking to reach out to were easily accessible and happy to speak with us, allowing for easy networking in a comfortable environment.

Business Development Manager, Neta Scientific

Well organized, interaction among attendees facilitated by organizers was excellent, interesting talks.

Vice President - Global Pharma Sales, Specs

Well organized, caliber of presentations and knowledge share was excellent.

Director - Outsourcing & Procurement, Anaptys Biosciences

The presentations were interesting & relevant. The topics were well chosen & the presenters were engaging. I enjoyed meeting & engaging w/ my peers, as well as the presenters.

Senior Procurement Manager, Biogen

Explore The Full Event Guide

Find out how your peers are really solving the problems on your desk right now, from shrinking CRO leverage to BIOSECURE exposure, through candid case studies from BMS, Takeda, AstraZeneca, Vertex and Revolution Medicines, not generic procurement theory.
Get hands-on with agentic AI in step-by-step tutorials where you build your own working agent on a real procurement task, guided by peers who’ve already deployed AI in sourcing, so you leave with a prototype, not just notes.
Benchmark your team against the industry, from AI maturity to the spend threshold where procurement gets involved, with live polls that show exactly where you stand against the room.
Discover the suppliers and platforms worth your time. Past attendees have found new partners here and gone on to implement them across their organizations.
24+ Speakers faculty built entirely for R&D procurement. 50% Director level or above from BMS, Takeda, Vertex, Pfizer and more, with 13 companies new for 2027.